Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL
tel-00827710, version 1 - 29 May 2013 II. CHARACTERIZATION OF THE T CELL RESPONSE Once the tetramer-enrichment technique was developed and validated in our hands, it was used to characterize the CD8 + T cell response in our model of cross-presentation to examine the impact of route of immunization, i.d. or i.v., on the establishment of the T cell response. A. Kinetic of CD8 + T cell response To determine the optimal conditions for achieving cross-priming, we compared the effects of immunizing with a local versus systemic dissemination of cell-associated antigen. C57BL/6 mice were injected i.d. or i.v. with live splenocytes from H-2K bm1 mice engineered to express a membrane-bound form of chicken ovalbumin in all tissues (referred to as K bm1 mOva). Use of membrane-associated Ovalbumin (mOva) ensured that our model was not confounded by secreted protein captured by endocytosis; and an altered K b molecule (known as K bm1 ) ensured a role for host presenting cells in the cross-priming of CD8 + T cells. In order to precisely monitor the priming of the endogenous T cell repertoire, we utilized K b -SIINFEKL tetramer-based enrichment, thus allowing precise enumeration and phenotypic analysis of Ovalbumin peptide-specific T cells at early time points after immunization. Accumulation of tetramer-positive cells could be observed as early as day 5 for i.v. immunization (Figure 21A), with cells showing downregulation of CD62L (Figure 21B) and expression of CD25 (Figure 21C). In contrast, the kinetics of T cell priming was delayed when cell-associated antigen was delivered via the i.d. route. In the latter condition, accumulation of Ova-specific CD8 + T cells was not observed until day 7 post-immunization. For both routes of immunization, antigen-specific T cells accumulated over time, with day 9-12 being the peak of the response (Figure 21A). These data demonstrated that the local delivery of cell- associated antigen results in delayed T cell cross-priming. 90
tel-00827710, version 1 - 29 May 2013 Figure 21. Route of immunization influences the kinetic of T cell response. Mice were immunized intradermally (ID) or intravenously (IV) with 5x10 5 K bm1 mOva splenocytes. On days 5, 7, 9, 12, 14 macroscopic lymph nodes and spleen were harvested and a K b -SIINFEKL tetramer-based enrichment was performed. (A) Absolute numbers of Ova-specific CD8 + T cells at each of the time points were determined. Data points indicate a single mouse. Results are representative of four independent experiments. The distributions according to the two immunization routes were not significantly different over time employing a general linear modeling analysis. CD62L (B) and CD25 (C) stainings are shown. While prior studies suggest that the precursor frequency of Ova-specific T cells is similar across individual C57BL/6 mice (Obar et al., 2008), it is true that each mouse possesses distinct T cell repertoires (Bousso et al., 1998). In addition, we wanted to confirm that the delayed priming was not a result of inability to access high affinity Ova-specific T cells. Thus we employed the strategy of adoptive transfer of low numbers (10 3 ) of monoclonal OT-I T cells (Badovinac et al., 2007), transferred one day prior to immunization. On day 5, tetramer- based enrichment was performed using a combination of anti-CD45.1 antibody and K b - SIINFEKL tetramer, permitting for the simultaneous assessment of the transferred CD45.1 + Page 91 of 256
- Page 39 and 40: tel-00827710, version 1 - 29 May 20
- Page 41 and 42: tel-00827710, version 1 - 29 May 20
- Page 43 and 44: tel-00827710, version 1 - 29 May 20
- Page 45 and 46: tel-00827710, version 1 - 29 May 20
- Page 47 and 48: tel-00827710, version 1 - 29 May 20
- Page 49 and 50: tel-00827710, version 1 - 29 May 20
- Page 51 and 52: tel-00827710, version 1 - 29 May 20
- Page 53 and 54: tel-00827710, version 1 - 29 May 20
- Page 55 and 56: tel-00827710, version 1 - 29 May 20
- Page 57 and 58: tel-00827710, version 1 - 29 May 20
- Page 59 and 60: tel-00827710, version 1 - 29 May 20
- Page 61 and 62: tel-00827710, version 1 - 29 May 20
- Page 63 and 64: tel-00827710, version 1 - 29 May 20
- Page 65 and 66: tel-00827710, version 1 - 29 May 20
- Page 67 and 68: tel-00827710, version 1 - 29 May 20
- Page 69 and 70: tel-00827710, version 1 - 29 May 20
- Page 71 and 72: tel-00827710, version 1 - 29 May 20
- Page 73 and 74: tel-00827710, version 1 - 29 May 20
- Page 75 and 76: tel-00827710, version 1 - 29 May 20
- Page 77 and 78: tel-00827710, version 1 - 29 May 20
- Page 79 and 80: tel-00827710, version 1 - 29 May 20
- Page 81 and 82: tel-00827710, version 1 - 29 May 20
- Page 83 and 84: tel-00827710, version 1 - 29 May 20
- Page 85 and 86: tel-00827710, version 1 - 29 May 20
- Page 87 and 88: tel-00827710, version 1 - 29 May 20
- Page 89: tel-00827710, version 1 - 29 May 20
- Page 93 and 94: tel-00827710, version 1 - 29 May 20
- Page 95 and 96: tel-00827710, version 1 - 29 May 20
- Page 97 and 98: tel-00827710, version 1 - 29 May 20
- Page 99 and 100: tel-00827710, version 1 - 29 May 20
- Page 101 and 102: tel-00827710, version 1 - 29 May 20
- Page 103 and 104: tel-00827710, version 1 - 29 May 20
- Page 105 and 106: tel-00827710, version 1 - 29 May 20
- Page 107 and 108: tel-00827710, version 1 - 29 May 20
- Page 109 and 110: tel-00827710, version 1 - 29 May 20
- Page 111 and 112: tel-00827710, version 1 - 29 May 20
- Page 113 and 114: tel-00827710, version 1 - 29 May 20
- Page 115 and 116: tel-00827710, version 1 - 29 May 20
- Page 117 and 118: tel-00827710, version 1 - 29 May 20
- Page 119 and 120: tel-00827710, version 1 - 29 May 20
- Page 121 and 122: tel-00827710, version 1 - 29 May 20
- Page 123 and 124: tel-00827710, version 1 - 29 May 20
- Page 125 and 126: tel-00827710, version 1 - 29 May 20
- Page 127 and 128: tel-00827710, version 1 - 29 May 20
- Page 129 and 130: tel-00827710, version 1 - 29 May 20
- Page 131 and 132: tel-00827710, version 1 - 29 May 20
- Page 133 and 134: tel-00827710, version 1 - 29 May 20
- Page 135 and 136: tel-00827710, version 1 - 29 May 20
- Page 137 and 138: tel-00827710, version 1 - 29 May 20
- Page 139 and 140: tel-00827710, version 1 - 29 May 20
tel-00827710, version 1 - 29 May 2013<br />
II. CHARACTERIZATION OF THE T CELL RESPONSE<br />
Once the t<strong>et</strong>ramer-enrichment technique was <strong>de</strong>veloped and validated in our hands, it was<br />
used to characterize the CD8 + T cell response in our mo<strong>de</strong>l of cross-presentation to examine<br />
the impact of route of immunization, i.d. or i.v., on the establishment of the T cell response.<br />
A. Kin<strong>et</strong>ic of CD8 + T cell response<br />
To d<strong>et</strong>ermine the optimal conditions for achieving cross-priming, we compared the effects of<br />
immunizing with a local versus systemic dissemination of cell-associated antigen. C57BL/6<br />
mice were injected i.d. or i.v. with live splenocytes from H-2K bm1 mice engineered to express<br />
a membrane-bound form of chicken ovalbumin in all tissues (referred to as K bm1 mOva). Use<br />
of membrane-associated Ovalbumin (mOva) ensured that our mo<strong>de</strong>l was not confoun<strong>de</strong>d by<br />
secr<strong>et</strong>ed protein captured by endocytosis; and an altered K b molecule (known as K bm1 )<br />
ensured a role for host presenting cells in the cross-priming of CD8 + T cells. In or<strong>de</strong>r to<br />
precisely monitor the priming of the endogenous T cell repertoire, we utilized K b -SIINFEKL<br />
t<strong>et</strong>ramer-based enrichment, thus allowing precise enumeration and phenotypic analysis of<br />
Ovalbumin pepti<strong>de</strong>-specific T cells at early time points after immunization. Accumulation of<br />
t<strong>et</strong>ramer-positive cells could be observed as early as day 5 for i.v. immunization (Figure<br />
21A), with cells showing downregulation of CD62L (Figure 21B) and expression of CD25<br />
(Figure 21C). In contrast, the kin<strong>et</strong>ics of T cell priming was <strong>de</strong>layed when cell-associated<br />
antigen was <strong>de</strong>livered via the i.d. route. In the latter condition, accumulation of Ova-specific<br />
CD8 + T cells was not observed until day 7 post-immunization. For both routes of<br />
immunization, antigen-specific T cells accumulated over time, with day 9-12 being the peak<br />
of the response (Figure 21A). These data <strong>de</strong>monstrated that the local <strong>de</strong>livery of cell-<br />
associated antigen results in <strong>de</strong>layed T cell cross-priming.<br />
90